Newsletter Archive

  1. 10.19.20 -- Companies To Watch: Osivax 10/19/2020
    10/19/20 Life Science Leader Newsletter
  2. 10.19.20 -- How Drug Development Benefits From End-To-End Thinking 10/19/2020
    10/19/20 Life Science Leader Newsletter
  3. 10.16.20 -- How A Non-Scientist Identifies The Right Scientific Talent 10/16/2020
    10/16/20 Life Science Leader Newsletter
  4. 10.15.20 -- Considerations For Outsourcing, CDMO Selection, And Process Characterization 10/15/2020
    10/15/20 Life Science Leader Newsletter
  5. 10.15.20 -- Considerations For Transforming Clinical Trials 10/15/2020
    10/15/20 Life Science Leader Newsletter
  6. 10.14.20 -- Changing The Status Quo Regarding Diversity In Clinical Trials 10/14/2020
    10/14/20 Life Science Leader Newsletter
  7. 10.14.20 -- Considerations For Formulation Development In Biologics Production 10/14/2020
    10/14/20 Life Science Leader Newsletter
  8. 10.13.20 -- Can Your Clinical Data Strategy Keep Pace? 10/13/2020
    10/13/20 Life Science Leader Newsletter
  9. 10.12.20 -- Pharma Research: What Makes Outsourcers Very Satisfied? 10/12/2020
    10/12/20 Life Science Leader Newsletter
  10. 10.09.20 -- COVID Revs Up The Antibiotics Space 10/9/2020
    10/09/20 Life Science Leader Newsletter